TBMED is an EU-funded collaborative research project which aims to increase patients’ access to high-risk medical devices, by helping SMEs to minimize time-to-market and the reimbursement process time, thus optimizing the process of transforming a prototype into a valuable innovative MD.

TBMED will establish an Open Innovation Test Bed (OITB) consisting of a connected network of labs providing a single entry point to services along the whole value chain from preclinical development to clinical testing. The entire process is based on a Quality-by-Design (QbD) concept.

The objectives of the project are: